Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a rand... by Haiying Ding, Wenxiu Xin, Qilu Fang, Xiaowei Zheng, Yinghui Tong, Gaoqi Xu, Guonong Yang

Get full text